Bio-Techne Corp
NASDAQ:TECH
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
61.66
84.15
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Bio-Techne Corp
Wall Street
Price Targets
TECH Price Targets Summary
Bio-Techne Corp
According to Wall Street analysts, the average 1-year price target for
TECH
is 87.11 USD
with a low forecast of 75.75 USD and a high forecast of 99.75 USD.
TECH Last Price Targets
Bio-Techne Corp
The latest public price target was made on Oct 31, 2024 by
Catherine Schulte
from
Robert W. Baird
,
who expects
TECH
stock to
rise by 18%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Catherine Schulte
Robert W. Baird
|
84
USD
Upside 18% |
3 weeks ago
Oct 31, 2024
|
Bio-Techne Corp. (TECH) PT Raised to $84 at Baird
StreetInsider
|
Paul Knight
KeyBanc
|
80
USD
Upside 12% |
3 weeks ago
Oct 30, 2024
|
KeyBanc Reiterates Overweight Rating on Bio-Techne Corp. (TECH)
StreetInsider
|
Sung Ji Nam
Scotiabank
|
83
USD
Upside 16% |
3 months ago
Aug 16, 2024
|
Scotiabank Reiterates Sector Outperform Rating on Bio-Techne Corp. (TECH)
StreetInsider
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is TECH's stock price target?
Price Target
87.11
USD
According to Wall Street analysts, the average 1-year price target for
TECH
is 87.11 USD
with a low forecast of 75.75 USD and a high forecast of 99.75 USD.
What is Bio-Techne Corp's Revenue forecast?
Projected CAGR
9%
For the last 8 years the
compound annual growth rate for
Bio-Techne Corp's revenue is
11%.
The projected
CAGR
for the next 3 years is
9%.
What is Bio-Techne Corp's Operating Income forecast?
Projected CAGR
25%
For the last 8 years the
compound annual growth rate for
Bio-Techne Corp's operating income is
6%.
The projected
CAGR
for the next 3 years is
25%.
What is Bio-Techne Corp's Net Income forecast?
Projected CAGR
35%
For the last 8 years the
compound annual growth rate for
Bio-Techne Corp's net income is
6%.
The projected
CAGR
for the next 3 years is
35%.
You don't have any saved screeners yet
